Management tracks: Sarepta, Gilead

Neuromuscular disease company Sarepta Therapeutics Inc. (NASDAQ:SRPT) hired Louise Rodino-Klapac as VP of gene therapy at its newly created gene therapy unit. She will continue to serve as acting CSO at Myonexus Therapeutics Inc. (New Albany, Ohio).

Gilead Sciences Inc. (NASDAQ:GILD) said EVP of Strategy Martin Silverstein will step down at the end of August. He is succeeded by SVP of Corporate Development Andrew Dickinson as EVP of corporate development and strategy...